• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种 RGD 修饰的 MRI 可见聚合物载体,用于裸鼠肝癌的靶向 siRNA 递释。

An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.

机构信息

Molecular Imaging Lab, Department of Radiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

PLoS One. 2013 Jun 7;8(6):e66416. doi: 10.1371/journal.pone.0066416. Print 2013.

DOI:10.1371/journal.pone.0066416
PMID:23922634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3676333/
Abstract

RNA interference (RNAi) has significant therapeutic promise for the genetic treatment of hepatocellular carcinoma (HCC). Targeted vectors are able to deliver small interfering RNA (siRNA) into HCC cells with high transfection efficiency and stability. The tripeptide arginine glycine aspartic acid (RGD)-modified non-viral vector, polyethylene glycol-grafted polyethylenimine functionalized with superparamagnetic iron oxide nanoparticles (RGD-PEG-g-PEI-SPION), was constructed as a magnetic resonance imaging (MRI)-visible nanocarrier for the delivery of Survivin siRNA targeting the human HCC cell line Bel-7402. The biophysical characterization of the RGD-PEG-g-PEI-SPION was performed. The RGD-modified complexes exhibited a higher transfection efficiency in transferring Survivin siRNA into Bel-7402 cells compared with a non-targeted delivery system, which resulted in more significant gene suppression at both the Survivin mRNA and protein expression levels. Then, the level of caspase-3 activation was significantly elevated, and a remarkable level of tumor cell apoptosis was induced. As a result, the tumor growth in the nude mice Bel-7402 hepatoma model was significantly inhibited. The targeting ability of the RGD-PEG-g-PEI-SPION was successfully imaged by MRI scans performed in vitro and in vivo. Our results strongly indicated that the RGD-PEG-g-PEI-SPION can potentially be used as a targeted non-viral vector for altering gene expression in the treatment of hepatocellular carcinoma and for detecting the tumor in vivo as an effective MRI probe.

摘要

RNA 干扰(RNAi)在肝细胞癌(HCC)的基因治疗方面具有重要的治疗前景。靶向载体能够将小干扰 RNA(siRNA)高效稳定地递送至 HCC 细胞。三肽精氨酸甘氨酸天冬氨酸(RGD)修饰的非病毒载体,聚乙二醇接枝的超顺磁性氧化铁纳米粒子功能化的聚乙烯亚胺(RGD-PEG-g-PEI-SPION),被构建为一种磁共振成像(MRI)可见的纳米载体,用于递送针对人 HCC 细胞系 Bel-7402 的 Survivin siRNA。对 RGD-PEG-g-PEI-SPION 的生物物理特性进行了表征。与非靶向递送系统相比,RGD 修饰的复合物在将 Survivin siRNA 转染入 Bel-7402 细胞中表现出更高的转染效率,从而导致 Survivin mRNA 和蛋白表达水平的基因抑制更为显著。然后,caspase-3 的激活水平显著升高,诱导了显著水平的肿瘤细胞凋亡。结果,裸鼠 Bel-7402 肝癌模型中的肿瘤生长受到显著抑制。通过体外和体内 MRI 扫描成功地对 RGD-PEG-g-PEI-SPION 的靶向能力进行了成像。我们的研究结果强烈表明,RGD-PEG-g-PEI-SPION 可作为一种潜在的靶向非病毒载体,用于改变肝细胞癌的基因表达,并作为有效的 MRI 探针在体内检测肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/9c8e8886f572/pone.0066416.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/d1d20cd6d95b/pone.0066416.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/0f8cdfc6a86e/pone.0066416.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/1ff77b13309d/pone.0066416.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/1fc5f8e73bf8/pone.0066416.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/f331019457c1/pone.0066416.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/6f258d85d7e5/pone.0066416.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/82f8368c72e9/pone.0066416.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/9c8e8886f572/pone.0066416.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/d1d20cd6d95b/pone.0066416.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/0f8cdfc6a86e/pone.0066416.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/1ff77b13309d/pone.0066416.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/1fc5f8e73bf8/pone.0066416.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/f331019457c1/pone.0066416.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/6f258d85d7e5/pone.0066416.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/82f8368c72e9/pone.0066416.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/985d/3676333/9c8e8886f572/pone.0066416.g008.jpg

相似文献

1
An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.一种 RGD 修饰的 MRI 可见聚合物载体,用于裸鼠肝癌的靶向 siRNA 递释。
PLoS One. 2013 Jun 7;8(6):e66416. doi: 10.1371/journal.pone.0066416. Print 2013.
2
Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo.聚乙二醇接枝聚亚胺和超顺磁性氧化铁纳米粒子(PEG-g-PEI-SPION)的表征作为一种 MRI 可见载体,用于体外和体内胃癌的 siRNA 递送。
J Gastroenterol. 2013 Jul;48(7):809-21. doi: 10.1007/s00535-012-0713-x. Epub 2012 Nov 20.
3
[Application of hepatocellular carcinoma targeted multifunctional nanocarriers].[肝细胞癌靶向多功能纳米载体的应用]
Zhonghua Yi Xue Za Zhi. 2014 Dec 23;94(47):3767-70.
4
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma.一种 MRI 可见的非病毒载体,用于将靶向 Bcl-2 的 siRNA 递送至神经母细胞瘤。
Int J Nanomedicine. 2012;7:3319-32. doi: 10.2147/IJN.S32900. Epub 2012 Jul 2.
5
Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer.开发一种用于靶向胃癌的 MRI 可见非病毒载体的 siRNA 递送系统。
Int J Nanomedicine. 2012;7:359-68. doi: 10.2147/IJN.S24083. Epub 2012 Jan 31.
6
Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.多功能聚合物纳米粒经口服递呈 shRNA 和 siRNA 用于协同癌症治疗。
Biomaterials. 2014 May;35(15):4589-600. doi: 10.1016/j.biomaterials.2014.02.027. Epub 2014 Mar 6.
7
Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.聚亚乙基亚胺和半乳糖修饰的超顺磁性氧化铁纳米颗粒用于肝细胞癌治疗中的 siRNA 靶向递送。
Int J Nanomedicine. 2018 Mar 26;13:1851-1865. doi: 10.2147/IJN.S155537. eCollection 2018.
8
Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.治疗诊断纳米系统鉴定肝癌中的癌基因和高效疗法。
Hepatology. 2016 Apr;63(4):1240-55. doi: 10.1002/hep.28409. Epub 2016 Feb 19.
9
Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.叶酸功能化聚乙烯亚胺超顺磁性氧化铁纳米颗粒作为用于胃癌磁共振成像和PD-L1小干扰RNA递送的诊疗试剂
Int J Nanomedicine. 2017 Jul 26;12:5331-5343. doi: 10.2147/IJN.S137245. eCollection 2017.
10
Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.谷胱甘肽敏感型 RGD-聚乙二醇-SS-聚醚酰亚胺用于颅内神经胶质瘤的靶向基因递释。
J Gene Med. 2013 Aug-Sep;15(8-9):291-305. doi: 10.1002/jgm.2726.

引用本文的文献

1
Navigating liver cancer: Precision targeting for enhanced treatment outcomes.应对肝癌:精准靶向治疗以提高治疗效果。
Drug Deliv Transl Res. 2025 Jun;15(6):1935-1961. doi: 10.1007/s13346-024-01780-x. Epub 2025 Jan 23.
2
Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA).利用小干扰RNA(siRNA)靶向肝癌干细胞(CSCs)及相关耐药性
Cell Biochem Biophys. 2024 Dec;82(4):3031-3051. doi: 10.1007/s12013-024-01423-5. Epub 2024 Jul 26.
3
Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies.

本文引用的文献

1
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma.一种 MRI 可见的非病毒载体,用于将靶向 Bcl-2 的 siRNA 递送至神经母细胞瘤。
Int J Nanomedicine. 2012;7:3319-32. doi: 10.2147/IJN.S32900. Epub 2012 Jul 2.
2
RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells.RGD 肽介导的壳聚糖基聚合物胶束靶向递药系统用于整合素过表达肿瘤细胞。
Int J Nanomedicine. 2011;6:3499-508. doi: 10.2147/IJN.S26670. Epub 2011 Dec 21.
3
Special delivery: targeted therapy with small RNAs.
用于靶向给药的肽介导纳米载体:进展与策略
Pharmaceutics. 2024 Feb 6;16(2):240. doi: 10.3390/pharmaceutics16020240.
4
Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors.小干扰RNA在胃肠道肿瘤中的潜在应用
Pharmaceuticals (Basel). 2022 Oct 20;15(10):1295. doi: 10.3390/ph15101295.
5
Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment.基于磁共振成像的用于肝细胞癌诊断和治疗的靶向分子影像学探针。
Biosensors (Basel). 2022 May 17;12(5):342. doi: 10.3390/bios12050342.
6
RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?用于调控肝细胞癌异常信号通路的RNA治疗选择:梦想还是现实?
Front Oncol. 2022 May 4;12:891812. doi: 10.3389/fonc.2022.891812. eCollection 2022.
7
Enhanced fluorescence/magnetic resonance dual imaging and gene therapy of liver cancer using cationized amylose nanoprobe.使用阳离子化直链淀粉纳米探针的肝癌增强荧光/磁共振双成像及基因治疗
Mater Today Bio. 2022 Feb 15;13:100220. doi: 10.1016/j.mtbio.2022.100220. eCollection 2022 Jan.
8
Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment.纳米医学在肝细胞癌中的应用:靶向癌症治疗的新前沿
Pharmaceutics. 2021 Dec 25;14(1):41. doi: 10.3390/pharmaceutics14010041.
9
Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness.聚合物介导的 siRNA 递送至肝细胞癌:影响特异性和有效性的变量。
Molecules. 2018 Mar 28;23(4):777. doi: 10.3390/molecules23040777.
10
A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy.一种靶向骨吸收表面的纳米颗粒,用于递送抗miR214治疗骨质疏松症。
Int J Nanomedicine. 2017 Oct 13;12:7469-7482. doi: 10.2147/IJN.S139775. eCollection 2017.
特需快递:小 RNA 靶向治疗。
Gene Ther. 2011 Dec;18(12):1127-33. doi: 10.1038/gt.2011.56. Epub 2011 Apr 14.
4
Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression.下调血栓调节蛋白通过增加 ZEB1 和减少 E-钙黏蛋白基因表达促进 HCC 细胞迁移。
Ann Surg Oncol. 2010 Dec;17(12):3379-85. doi: 10.1245/s10434-010-1163-4. Epub 2010 Jul 13.
5
The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro.聚合物-siRNA 纳米粒用于胃癌基因治疗的体外研究。
Int J Nanomedicine. 2010 Mar 9;5:129-36. doi: 10.2147/ijn.s8503.
6
Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging.体内条件下聚(亚乙基亚胺)和聚(亚乙基亚胺)-g-聚(乙二醇)的 siRNA 多聚物的稳定性:通过荧光波动光谱和单光子发射计算机断层扫描(SPECT)成像测量对药代动力学和生物分布的影响。
J Control Release. 2009 Sep 1;138(2):148-59. doi: 10.1016/j.jconrel.2009.05.016. Epub 2009 May 19.
7
MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression.用于基因传递至T细胞以实现免疫抑制的携带CD3单链抗体的MRI可见聚合物载体
Biomaterials. 2009 Apr;30(10):1962-70. doi: 10.1016/j.biomaterials.2008.12.043. Epub 2009 Jan 21.
8
Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.使用聚电解质复合胶束进行VEGF小干扰RNA的局部和全身递送以有效治疗癌症。
J Control Release. 2008 Jul 14;129(2):107-16. doi: 10.1016/j.jconrel.2008.03.008. Epub 2008 Mar 14.
9
Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells.Jak抑制剂可诱导人肝癌细胞发生S期细胞周期阻滞,并增强TRAIL诱导的细胞凋亡。
Biochem Biophys Res Commun. 2007 Nov 23;363(3):738-44. doi: 10.1016/j.bbrc.2007.09.049. Epub 2007 Sep 21.
10
Interfering with disease: a progress report on siRNA-based therapeutics.干预疾病:基于小干扰RNA疗法的进展报告
Nat Rev Drug Discov. 2007 Jun;6(6):443-53. doi: 10.1038/nrd2310.